"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"

What this episode covers

Visit https://www.peervoice.com/BGE860 to view the entire programme with slides. After completing “"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"”, participants will be able to: Summarise the impact of COVID-19 preventive measures on patients’ atopic dermatitis (AD) activity; Explain the difference in COVID-related outcomes in patients on immunomodulatory therapies for AD compared with patients who are not receiving immunomodulatory therapy for AD; Propose practical COVID-19 vaccine strategies for patients with AD who are receiving a biologic agent

Distinct summary based on available episode metadata or transcript content.